Noninvasive Assessment of Impaired Gas Exchange with the Alveolar Gas Monitor Predicts Clinical Deterioration in COVID-19 Patients.
W Cameron McGuireAlex K PearceAnn R ElliottJanelle M FineJohn B WestDaniel R CrouchG Kim PriskAtul MalhotraPublished in: Journal of clinical medicine (2023)
The AGM100 is a novel, noninvasive way of measuring impaired gas exchange for clinically important endpoints in COVID-19.